Developer docs
API playgroundTry for free, no card

Search company profiles

Sinemia

Full company profile

uuid0004sa6

Namestring
Sinemia
Websiteurl
sinemia.com
Company typeenum
Private
Founded yearint
2015
Short descriptiontext

Sinemia is a US-based, private subscription service founded in 2015 in Los Angeles that offers monthly movie ticket access to individual consumers, positioning itself additionally as a social platform for moviegoers. The company is led by founder and CEO Rıfat Oğuz and operates with 11–50 employees.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLos Angeles, United States
HQ citystring
Los Angeles
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
movie subscription service, cinema membership, theater ticket plans, social moviegoer platform, monthly movie pass
NAICS code1 code
  • Media Streaming Distribution Services, Social Networks, and Other Media Networks and Content Providers5162
SIC code1 code
  • Services-Motion Picture Theaters7830
Product category
Movie Subscription Services
Social media profiles2 records
Cost components4 values
Operations, Marketing or Sales, Technology or R&D, Personnel
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Sinemia is a monthly subscription-based service that gives individual moviegoers access to movie showings at participating theaters for a recurring fee. The offering is paired with a social platform where users can engage around the moviegoing experience. Memberships are sold directly to consumers via web and mobile channels.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Sinemia Monthly Movie Subscription
CategoryMovie Subscription Service
No data
Peers7 records
TypeEmerging player
Description

Atom Tickets is a social movie ticketing app that combines discovery, social features, and ticket purchasing. It overlaps with Sinemia's social-platform-for-moviegoers positioning, though it is transactional rather than subscription-based.

TypeBroad incumbent
Description

While a streaming subscription rather than theatrical access, Netflix competes for the same entertainment wallet share and pulls consumers away from theatrical moviegoing — a structural headwind for Sinemia's category.

TypeDirect peer
Description

Cinemark's Movie Club is a monthly subscription with monthly credits for movie tickets and discounts. It is a comparable theater-chain subscription program targeting the same Sinemia customer.

TypeDirect peer
Description

AMC's A-List is a monthly subscription offering unlimited movies at AMC locations. As a theater-chain-owned subscription program, it is the most direct substitute for Sinemia's value proposition.

TypeDirect peer
Description

Alamo Drafthouse operates subscription/season-pass programs for its theaters. It is a direct peer offering subscription access to moviegoing at a specific chain, similar in model to Sinemia.

TypeDirect peer
Description

MoviePass is the most well-known US movie theater subscription service, charging a monthly fee for access to theater screenings. It is a direct competitor to Sinemia's core subscription-moviegoing model.

7Regal Cinemas (Regal Unlimited)
TypeDirect peer
Description

Regal Unlimited is a monthly subscription granting access to screenings at Regal theaters. It competes head-to-head with Sinemia in the same movie-subscription category.

Market position
Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sinemia

Movie Subscription Servicessinemia.com

Sinemia is a US-based, private subscription service founded in 2015 in Los Angeles that offers monthly movie ticket access to individual consumers, positioning itself additionally as a social platform for moviegoers. The company is led by founder and CEO Rıfat Oğuz and operates with 11–50 employees.

Sinemia firmographics

Firmographics
Name
Sinemia
Website
https://sinemia.com
Company type
Private
Founded year
2015
Headcount range
11–50 employees
Short description
Sinemia is a US-based, private subscription service founded in 2015 in Los Angeles that offers monthly movie ticket access to individual consumers, positioning itself additionally as a social platform for moviegoers. The company is led by founder and CEO Rıfat Oğuz and operates with 11–50 employees.
Ownership category
akta.pro rank

Where Sinemia is headquartered

Location

Headquarters

HQ city
Los Angeles
HQ country
United States
HQ region
North America

Markets served

Sinemia business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Operations, Marketing or Sales, Technology or R&D, Personnel

Sinemia product offering

Product offering

Core offering

Sinemia is a monthly subscription-based service that gives individual moviegoers access to movie showings at participating theaters for a recurring fee. The offering is paired with a social platform where users can engage around the moviegoing experience. Memberships are sold directly to consumers via web and mobile channels.

Differentiator

Problem solved

Functional benefit

Products and services

  • Sinemia Monthly Movie Subscription

Companies that use Sinemia

Customer profile

Ideal customer profiles1 record

Sinemia technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Sinemia competitors and assessment

Company assessment

Emerging players

  • Atom Tickets: Atom Tickets is a social movie ticketing app that combines discovery, social features, and ticket purchasing. It overlaps with Sinemia's social-platform-for-moviegoers positioning, though it is transactional rather than subscription-based.

Broad incumbents

  • Netflix: While a streaming subscription rather than theatrical access, Netflix competes for the same entertainment wallet share and pulls consumers away from theatrical moviegoing — a structural headwind for Sinemia's category.

Direct peers

  • Cinemark Movie Club: Cinemark's Movie Club is a monthly subscription with monthly credits for movie tickets and discounts. It is a comparable theater-chain subscription program targeting the same Sinemia customer.
  • AMC Theatres (AMC Stubs A-List): AMC's A-List is a monthly subscription offering unlimited movies at AMC locations. As a theater-chain-owned subscription program, it is the most direct substitute for Sinemia's value proposition.
  • Alamo Drafthouse (Season Pass / Victory): Alamo Drafthouse operates subscription/season-pass programs for its theaters. It is a direct peer offering subscription access to moviegoing at a specific chain, similar in model to Sinemia.
  • MoviePass: MoviePass is the most well-known US movie theater subscription service, charging a monthly fee for access to theater screenings. It is a direct competitor to Sinemia's core subscription-moviegoing model.
  • Regal Cinemas (Regal Unlimited): Regal Unlimited is a monthly subscription granting access to screenings at Regal theaters. It competes head-to-head with Sinemia in the same movie-subscription category.

Market position

Customer concentration

Sinemia social profiles

Digital presence

Sinemia financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sinemia leadership team

Management profile

Number of profiles

Profiles1 record

Sinemia funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sinemia M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sinemia

What does Sinemia do?

Sinemia is a monthly subscription-based service that gives individual moviegoers access to movie showings at participating theaters for a recurring fee. The offering is paired with a social platform where users can engage around the moviegoing experience. Memberships are sold directly to consumers via web and mobile channels.

When was Sinemia founded?

Sinemia was founded in 2015. It employs 11 to 50 people.

Where is Sinemia based?

Sinemia is headquartered in Los Angeles, United States, in the North America region.

Who are Sinemia's main competitors?

Atom Tickets is listed as an emerging player. Netflix is listed as a broad incumbent. Direct peers are Cinemark Movie Club, AMC Theatres (AMC Stubs A-List), Alamo Drafthouse (Season Pass / Victory), MoviePass and Regal Cinemas (Regal Unlimited).

Does Sinemia have an API?

No public API is recorded for Sinemia.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business InsiderMoviePass competitor Sinemia says it won't give subscribers details on why it terminated their accountsSinemia terminated a significant number of subscriber accounts citing fraudulent activity while refusing to provide specific details to the affected users. Former subscribers have reported unfair cancellations and complaints regarding vague customer service responses and new processing fees, leading to a class-action lawsuit filed in November.The Mercury NewsProblem Solved: What’s with these transaction fees on my Sinemia tickets?Sinemia issued a full refund to two customers who paid $240 for a one-year subscription but faced undisclosed $1.80 transaction fees per ticket. The company had previously refused to acknowledge the issue, and a class action suit has been filed.Business InsiderMoviePass rival Sinemia says it's under 'pending' FTC investigation and files for bankruptcySinemia filed for Chapter 7 bankruptcy in Delaware and closed US operations, citing a pending FTC investigation and legal costs. The company listed $1.2 million in assets and $158,000 in liabilities, with two class-action lawsuits and a patent-infringement suit also pending.clevelandMovie subscription service Sinemia bites the dust in an ‘Endgame’ of its ownSinemia, a movie subscription service, abruptly ceased operations on Thursday, citing unsustainable competition from theaters and insufficient funds. The company, which faced a class-action lawsuit and patent infringement suit, left AMC, Cinemark, and MoviePass as remaining major services. No refunds were announced for subscribers who paid upfront.TechSpotSinemia, the MoviePass competitor, is shutting downSinemia is closing its US operations immediately, citing lack of cash, PR issues, and legal troubles. The company had offered unlimited plans and reduced prices, but MoviePass is suing over patent infringement. The closure may pressure MoviePass, which has also taken an emergency loan.Business InsiderMoviePass competitor Sinemia shuts down operations in the US as 'Avengers: Endgame' enters theatersSinemia shut down its US operations on Thursday, citing unsustainable competition from theaters building their own subscriptions. The company said legal costs and funding efforts were insufficient, and did not address refunds for prepaid customers. The closure comes as 'Avengers: Endgame' opens in theaters.TechCrunchMovie subscription service Sinemia is ending US operationsSinemia, a movie subscription service that competed with MoviePass, announced it is shutting down US operations effective immediately due to unsustainable business economics. The company cited mounting legal costs from lawsuits filed by MoviePass and frustrated customers over app problems, hidden charges, and abrupt account closures, combined with intense competition from theater chains like AMC offering their own services. It remains unclear whether Sinemia will continue operating in other markets including the UK, Canada, Australia, and Turkey, or what will happen to US customers owed money on their accounts.PYMNTS.comSolving The Subscription Movie PuzzleAtom Tickets announced a new movie theater subscription platform that lets operators build their own plans, aiming to avoid the pitfalls of one-size-fits-all services. The company, which already serves 22,000 screens, is in conversations with interested partners. Atom's approach focuses on exhibitor-set pricing and co-existing with a la carte ticketing.TechCrunchSinemia faces consumer pushback and a class action suit over a battery of complaintsSinemia is experiencing consumer pushback and a class action lawsuit due to widespread complaints about hidden fees, app problems, and account cancellations. The company has initiated measures such as launching new customer service websites and addressing issues publicly, amid ongoing legal and reputation challenges.VarietyJudge Allows MoviePass Patent Suit Against SinemiaA federal judge in Los Angeles denied Sinemia's motion to dismiss MoviePass's patent infringement suit, allowing the case to proceed. The judge found further fact-finding necessary, citing recent Federal Circuit decisions, despite skepticism about the invention's novelty.